Welcome to visit Zhongnan Medical Journal Press Series journal website!

Home Articles Vol 32,2023 No.3 Detail

Analysis and pharmacovigilance of traditional Chinese medicine prescriptions in cardiovascular department based on data mining

Published on Mar. 24, 2023Total Views: 1085 times Total Downloads: 404 times Download Mobile

Author: Meng-Ya JIN 1 Zhi-Yuan LI 2

Affiliation: 1. Department of Pharmacy, Dong Fang Hospital of Beijing University of Chinese Medicine, Beijing 100078, China 2. Department of Pharmacy, Beijing Ji Shuitan Hospital, Beijing 100035, China

Keywords: Prescription of traditional Chinese medicine Cardiovascular disease Compatibility rule Data mining Pharmacovigilance

DOI: 10.19960/j.issn.1005-0698.202303001

Reference: Meng-Ya JIN, Zhi-Yuan LI.Analysis and pharmacovigilance of traditional Chinese medicine prescriptions in cardiovascular department based on data mining[J].Yaowu Liuxingbingxue Zazhi,2023, 32(3): 241-248.DOI: 10.19960/j.issn.1005-0698.202303001.[Article in Chinese]

  • Abstract
  • Full-text
  • References
Abstract

Objective  To count the prescriptions for oral administration of traditional Chinese medicine in the cardiovascular department, analyze the characteristics of the use of traditional Chinese medicine prescriptions, and provide basis for the pharmacovigilance of traditional Chinese medicine.

Methods  Microsoft Excel software was used to analyze the data of oral Chinese medicine prescriptions of inpatients from 2019 to 2021 in the cardiovascular department of Dong Fang Hospital of Beijing University of Chinese Medicine, including the name and syndrome type of the inpatients, the frequency, and dosage of the use of prescription drugs, as well as the classification of the four qi, five flavors, and efficacy of commonly used Chinese medicines in the cardiovascular department. The association rules in the structured query language SQL server 2008 R2 software were used for data mining, to analyze the compatibility rules and core drugs of cardiovascular traditional Chinese medicine prescriptions, and to analyze the pharmacovigilance of cardiovascular traditional Chinese medicine.

Results Statistical analysis showed that Poria cocos, Salvia miltiorrhiza radix et rhizoma, Glycyrrhizae radix et rhizome praeparata cum melle, Codonopsis radix and Paeoniae radix rubra ranked the top 5 in the frequency of consumption. The top 30 TCMs were mainly sweet, spicy and warm; the heart and spleen are the main channels; the main effects are tonifying and promoting blood circulation and removing blood stasis. The common combinations of two drugs in cardiovascular department Glycyrrhizae radix et rhizome praeparata cum melle - Poria cocos, Citri reticulatae pericarpium- Poria cocos, Codonopsis radix - Poria cocos; Poria cocos, Salvia miltiorrhiza radix et rhizoma, Paeoniae radix rubra, Codonopsis radix, Astragall radix, Chuanxiong rhizome and Glycyrrhizae radix et rhizome praeparata cum melle are the core drugs of the prescription. These drugs are mainly used to treat cardiovascular diseases caused by qi deficiency, blood stasis and phlegm dampness. Except Codonopsis radix, the maximum dose of other Chinese herbal pieces exceeded the Pharmacopoeia limit.

Conclusion  The main symptoms of cardiovascular inpatients are Qi deficiency and blood stasis syndrome and phlegm dampness internal obstruction syndrome. The treatment is mainly based on the traditional Chinese medicine of invigorating Qi and activating blood circulation, and the core medication is mainly characterized by invigorating qi and spleen, activating blood and promoting dampness. There is a problem of overdose in commonly used prescriptions.

Full-text
Please download the PDF version to read the full text: download
References

1. 祁新安, 侯清江. SQL Server数据库的运用研究[J].制造业自动化, 2010, 32(14): 30-32. [Qi XA, Hou QJ. The use of SQL Server database[J]. Manufacturing Automation, 2010, 32(14): 30-32.] DOI: 10.3969/j.issn.1009-0134. 2010.12.10.

2. 汪明. SQL Server 2008 R2关联规则研究[J]. 电脑知识与技术, 2011, 7(16): 3774-3776. [Wang M. Research on association rules of SQL Server 2008 R2[J]. Computer Knowledge and Technology, 2011, 7(16): 3774-3776.] DOI: 10.3969/j.issn.1009-3044.2011.16.010.

3. 刘洪兴. 基于数据挖掘的仝小林教授辨治胰岛素抵抗经验初探[D]. 北京: 北京中医药大学, 2014.

4. 王晓霞, 韩媛媛, 师桂英, 等. 基于数据挖掘的中药治疗肿瘤用药分析及监护探讨[J]. 中国中药杂志, 2020, 45(2): 444-450. [Wang XX, Han YY, Shi GY, et al. Analysis and monitoring of traditional Chinese medicine for tumor treatment based on data mining[J]. Chinese Journal of Traditional Chinese Medicine, 2020, 45(2): 444-450.]DOI: 10.19540/j.cnki.cjcmm.20190513.501.

5. 袁敏, 魏子孝. 魏子孝治疗糖尿病用药特点分析[J]. 北京中医药, 2011, 30(2): 96-99. [Yuan M, Wei ZX. Analysis of the characteristics of Wei Zixiao's medication in treating diabetes[J]. Beijing Traditional Chinese Medicine, 2011, 30(2): 96-99.] DOI: CNKI:SUN:BJZO.0. 2011-02-006.

6. 中国药典2020年版. 一部[S]. 2020: 42-347.

7. 高学敏. 中医药高级丛书·中药学[M]. 北京: 人民卫生出版社, 2007: 53-486.

8. 吕建军, 李霞, 郝瑞春, 等. 基于数据挖掘分析含白术的成方制剂的组方规律[J]. 中国药房, 2018, 29(21): 2930-2934. [Lyu JJ, Li X, Hao RC, et al. Analysis of prescription rules of formulated preparations containing Atractylodes Macrocephala based on data mining[J]. Chinese Pharmacy, 2018, 29(21): 2930-2934.] DOI: CNKI:SUN:ZGYA.0.2018-21-012.

9. 李浅予, 汤岐梅, 侯雅竹, 等. 中药党参的心血管药理研究进展[J]. 中西医结合心脑血管病杂志, 2019, 17(17): 2604-2606. [Li QY, Tang QM, Hou YZ, et al. Advances in cardiovascular pharmacology of Codonopsis pilosula[J]. Journal of Cardiovascular and Cerebrovascular Diseases of Integrated Traditional Chinese and Western Medicine, 2019, 17(17): 2604-2606.] DOI: CNKI:SUN: ZYYY.0.2019-17-013.

10.Tsai KH, Lee NH, Chen GY, et al. Dung-shen ( Codonopsis pilosula) attenuated the cardiac-impaired insulin-like growth factor Ⅱ receptor pathway on myocardial cells[J]. Food Chem, 2013, 138(2-3): 1856-1867. DOI: 10.1016/j.foodchem.2012.11.056.

11.钟灵. 党参对心肌缺血/再灌注损伤家兔血流动力学和心肌酶的影响[J]. 中国老年学杂志, 2012, 32(5): 966-968. [Zhong L. Effects of Codonopsis pilosula on hemodynamics and myocardial enzymes in rabbits with myocardial ischemia/reperfusion injury[J]. Chinese Journal of Gerontology, 2012, 32(5): 966-968.] DOI: 10.3969/j.issn.1005-9202.2012.05.036.

12.王军, 张虹, 谢凤杰, 等. 甘草酸预处理对大鼠心肌缺血再灌注损伤的保护作用及Bcl-2和Bax表达的影响[J]. 中国实验方剂学杂志, 2018, 24(6): 126. [Wang J, Zhang H, Xie FJ, et al. Protective effect of glycyrrhizic acid preconditioning on myocardial ischemia-reperfusion injury and the expression of Bcl-2 and Bax in rats[J]. Chinese Journal of Experimental Formulas, 2018, 24(6): 126.] DOI: 10.13422/j.cnki.syfjx.20180698.

13.余鑫鑫, 陈阳. 甘草酸对缺血/再灌注大鼠心肌细胞凋亡的影响及机制探讨[J]. 山东医药, 2018, 58(6): 38. [Yu XX, Chen Y. Effect of glycyrrhizic acid on myocardial cell apoptosis in ischemia/reperfusion rats and its mechanism[J]. Shandong Medicine, 2018, 58(6): 38.] DOI: 10.3969/j.issn.1002-266X.2018.06.010.

14.Chopra S, Cherian D, Verghese PP, et al. Physiology and clinical significance of natriuretic hormones[J]. Indian J Endocrinol Metab, 2013, 17(1): 83-90. DOI: 10.4103/2230-8210.107869.

15.李侠, 蒋长兴, 胡有东, 等. 茯苓多糖对异丙肾上腺素所致心肌肥厚大鼠心功能的影响[J]. 中华损伤与修复杂志(电子版), 2014, 9(4): 367-371.[Li X, Jiang CX, Hu YD, et al. Effect of Poria cocos polysaccharide on cardiac function in rats with myocardial hypertrophy induced by isoproterenol[J]. Chinese Journal of Damage and Repair (electronic edition), 2014, 9(4): 367-371.] DOI: 10.3877/cma.j.issn.1673-9450.2014.04.005.

16.周凤华, 李丽君, 李杰, 等. 丹参多糖保护H2O2致心肌细胞损伤作用机制[J].时珍国医国药, 2011, 22(12): 2889-2891. [Zhou FH, Li LJ, Li J, et al. Mechanism of Salvia miltiorrhiza polysaccharide protecting myocardial cells from H2O2 induced injury[J]. Shizhen Traditional Chinese Medicine Traditional Chinese Medicine, 2011, 22(12): 2889-2891.] DOI: 10.3969/j.issn.1008-0805.2011.12.026.

17.Song MB, Hiuang L, Zhao G, et al. Beneficial effects of a polysaccharide from Salvia miltiorrhiza on myocardial ischemia-reperfusion injury in rats[J].Carbohyd Polym, 2013, 98(2): 1631-1636. DOI: 10.1016/j.carbpol.2013. 08.020.

18.杨萍, 贾钰华, 李杰. 丹参酮ⅡA对缺血再灌注损伤大鼠心律失常及IMA、H-FABP水平的影响[J]. 中药新药与临床药理, 2009, 20(6): 517-521. [Yang P, Jia YH, Li J. Effects of tanshinone ⅡA on arrhythmia and levels of IMA and H-FABP in rats with ischemia reperfusion injury[J]. New Traditional Chinese Medicine and Clinical Pharmacology, 2009, 20(6): 517-521.] DOI: 10.3321/j.issn:1003-9783.2009.06.006.

19.张建成, 林淑琴, 胡鹏飞. 丹参多糖促进自噬抑制脂多糖诱导心肌细胞凋亡的实验研究[J]. 浙江中西医结合杂志, 2020, 30(4): 281-285, 349. [Zhang JC, Lin SQ, Hu PF. Experimental study on Salvia miltiorrhiza polysaccharides promoting autophagy and inhibiting apoptosis of myocardial cells induced by lipopolysaccharides[J]. Zhejiang Journal of Integrated Traditional and Western Medicine, 2020, 30(4): 281-285, 349.] DOI: CNKI:SUN:ZJZH.0.2020-04-009.

20.张淼, 金宇, 甘洁文, 等. 基于数据挖掘的心血管疾病气虚血瘀证组方配伍规律[J]. 中西医结合心脑血管病杂志, 2021, 19(8): 1247-1255. [Zhang M, Jin Y, Gan JW, et al. Data mining based compatibility rule of prescriptions for cardiovascular disease with qi deficiency and blood stasis syndrome[J]. Journal of Cardiovascular and Cerebrovascular Diseases of Integrated Traditional Chinese and Western Medicine, 2021, 19(8): 1247-1255.]DOI: 10.12102/j.issn.1672-1349.2021.08.003.

21.邱凤邹, 张斯汉, 陆燕萍. 超药典中药处方剂量分析[J]. 中外医疗, 2010, 29(23): 9-11. [Qiu FZ, Zhang SH, Lu YP. Dose analysis of traditional Chinese medicine prescriptions in super pharmacopoeia[J]. Chinese and Foreign Medical Treatment, 2010, 29(23): 9-11.] DOI: 10.3969/j.issn.1674-0742.2010.23.005.

22.韦姗姗, 焦拥政, 王丽霞, 等. 超量使用中药安全性的研究对策与思考[J]. 中医杂志, 2011, 52(19): 1623-1626. [Wei SS, Jiao YZ, Wang LX, et al. Research countermeasures and thoughts on the safety of excessive use of traditional Chinese medicine[J]. Journal of Traditional Chinese Medicine, 2011, 52(19): 1623-1626.] DOI: 10.1038/cdd.2010.68.

23.黄凤英, 高健美, 龚其海. 半夏药理作用及其毒性研究进展[J]. 天然产物研究与开发, 2020, 32(10): 1773-1781. [Huang FY, Gao JM, Gong QH. Research progress on pharmacological action and toxicity of Pinellia ternate[J]. Research and Development of Natural Products, 2020, 32(10): 1773-1781.] DOI: 10.16333/j.1001-6880.2020. 10.020.

24.乐正华. 葛根引起腹泻1例报告[J]. 中医药临床杂志, 2004, 16(1): 88. [Yue ZH. Diarrhea caused by pueraria lobata: a case report[J]. Clinical Journal of Traditional Chinese Medicine, 2004, 16(1): 88.] DOI: 10.3969/j.issn. 1672-7134.2004.01.077.

25.袁惠, 李亚琼, 廖明娟, 等. 中药处方药物剂量调查[J]. 中医杂志, 2012, 53(11): 974-976. [Yuan H, Li YQ, Liao MJ, et al. Investigation on the dose of prescriptions of traditional Chinese medicine[J]. Journal of Traditional Chinese Medicine, 2012, 53(11): 974-976.] DOI: CNKI:SUN:ZZYZ.0.2012-11-033.

26.陈岩, 白树才. 中药不同剂量应用综述[J]. 实用中医药杂志, 2004, 20(2): 110-111. [Chen Y, Bai SC. Review on the application of different doses of traditional Chinese medicine[J]. Journal of Practical Chinese Medicine, 2004, 20(2): 110-111.] DOI: 10.3969/j.issn.1004-2814. 2004.02.070.

Popular papers
Last 6 months